Classifications

• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
  • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
  • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P25/00—Drugs for disorders of the nervous system
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P25/00—Drugs for disorders of the nervous system
  • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P35/00—Antineoplastic agents
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
  • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
  • C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
  • C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
  • C07C317/00—Sulfones; Sulfoxides
  • C07C317/24—Sulfones; Sulfoxides having sulfone or sulfoxide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
  • C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
  • C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
  • C07D309/38—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms one oxygen atom in position 2 or 4, e.g. pyrones
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
  • C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
  • C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
  • C07D309/40—Oxygen atoms attached in positions 3 and 4, e.g. maltol
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
  • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
  • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

• Chemical & Material Sciences (AREA)
• Organic Chemistry (AREA)
• Health & Medical Sciences (AREA)
• General Chemical & Material Sciences (AREA)
• Medicinal Chemistry (AREA)
• Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
• Chemical Kinetics & Catalysis (AREA)
• Pharmacology & Pharmacy (AREA)
• Life Sciences & Earth Sciences (AREA)
• Animal Behavior & Ethology (AREA)
• General Health & Medical Sciences (AREA)
• Public Health (AREA)
• Veterinary Medicine (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Engineering & Computer Science (AREA)
• Neurology (AREA)
• Neurosurgery (AREA)
• Biomedical Technology (AREA)
• Pain & Pain Management (AREA)
• Psychiatry (AREA)
• Hospice & Palliative Care (AREA)
• Rheumatology (AREA)
• Orthopedic Medicine & Surgery (AREA)
• Physical Education & Sports Medicine (AREA)
• Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
• Pyrane Compounds (AREA)
• Plural Heterocyclic Compounds (AREA)
• Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
• Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Applications Claiming Priority (3)

Publications (1)

Family

ID=26155180

Family Applications (1)

Country Status (34)

Families Citing this family (12)

Family Cites Families (17)

• 1999
  • 1999-09-15 TW TW088115924A patent/TW587079B/zh not_active IP Right Cessation
  • 1999-09-16 NZ NZ510625A patent/NZ510625A/xx not_active IP Right Cessation
  • 1999-09-16 CZ CZ20011058A patent/CZ300357B6/cs not_active IP Right Cessation
  • 1999-09-16 SK SK370-2001A patent/SK286471B6/sk not_active IP Right Cessation
  • 1999-09-16 SI SI9930232T patent/SI1115716T1/xx unknown
  • 1999-09-16 EP EP99947372A patent/EP1115716B1/en not_active Expired - Lifetime
  • 1999-09-16 WO PCT/EP1999/006873 patent/WO2000018753A1/en active IP Right Grant
  • 1999-09-16 HU HU0104620A patent/HUP0104620A3/hu unknown
  • 1999-09-16 CA CA002345069A patent/CA2345069C/en not_active Expired - Fee Related
  • 1999-09-16 ES ES99947372T patent/ES2190252T3/es not_active Expired - Lifetime
  • 1999-09-16 AU AU60847/99A patent/AU765653B2/en not_active Ceased
  • 1999-09-16 AT AT99947372T patent/ATE230405T1/de active
  • 1999-09-16 DK DK99947372T patent/DK1115716T3/da active
  • 1999-09-16 DE DE69904738T patent/DE69904738T2/de not_active Expired - Lifetime
  • 1999-09-16 EE EEP200100173A patent/EE04812B1/xx not_active IP Right Cessation
  • 1999-09-16 IL IL14208799A patent/IL142087A0/xx unknown
  • 1999-09-16 KR KR1020017003835A patent/KR100806684B1/ko not_active IP Right Cessation
  • 1999-09-16 MX MXPA01003069A patent/MXPA01003069A/es not_active IP Right Cessation
  • 1999-09-16 TR TR2001/00852T patent/TR200100852T2/xx unknown
  • 1999-09-16 BR BR9913939-1A patent/BR9913939A/pt not_active Application Discontinuation
  • 1999-09-16 RU RU2001111323/04A patent/RU2232158C2/ru not_active IP Right Cessation
  • 1999-09-16 CN CNB998125709A patent/CN1202104C/zh not_active Expired - Fee Related
  • 1999-09-16 PL PL99346895A patent/PL346895A1/xx not_active Application Discontinuation
  • 1999-09-16 JP JP2000572213A patent/JP4717211B2/ja not_active Expired - Fee Related
  • 1999-09-16 ID IDW20010685D patent/ID28624A/id unknown
  • 1999-09-21 MY MYPI99004101A patent/MY121793A/en unknown
  • 1999-09-23 PE PE1999000966A patent/PE20001067A1/es not_active Application Discontinuation
  • 1999-09-23 CO CO99060536A patent/CO5140127A1/es unknown
  • 1999-09-24 AR ARP990104836A patent/AR021826A1/es active IP Right Grant
  • 1999-09-25 EG EG118999A patent/EG23802A/xx active
• 2001
  • 2001-03-16 US US09/809,645 patent/US6518303B2/en not_active Expired - Fee Related
  • 2001-03-22 BG BG105373A patent/BG65308B1/bg unknown
  • 2001-03-23 NO NO20011512A patent/NO327987B1/no not_active IP Right Cessation
  • 2001-08-08 HK HK01105498A patent/HK1034961A1/xx not_active IP Right Cessation

Also Published As

Similar Documents